The World Healthทางเข้า xo walletOrganization (WHO) has announced the addition of a COVID-19 vaccine from US pharmaceutical manufacturer Novavax. Access to the list of vaccines available in an emergency It is the world's 10th coronavirus vaccine approved by the WHO after it received a green light from the European Medicines Agency on Monday (Dec 20).
Novavax's Nuvaxovid vaccine is made with protein-based technology. (protein-nanoparticle vaccine), in which parts of the spiny protein of the virus are used to stimulate immunity There is a relatively high security. And it has led Brussels officials to believe that it might lead people who are hesitant to decide to get vaccinated.
This technology has been used for decades to produce vaccines against diseases such as hepatitis B and whooping cough.
The WHO said that from two large clinical trials in Britain and the United States, In Mexico with more than 45,000 participants, Novavax's vaccine was found to be effective against COVID-19. Approximately 90% of the symptoms are present, while the Strategic Advisory Group of Experts to the WHO recommends the vaccine for people aged 18 years and over, with 2 injections approximately 3-d apart. 4 weeks
The vaccine can be refrigerated at temperatures between 2-8°C, making it easier to transport to rural areas where it is more difficult to access than mRNA vaccines, which must be kept at very low temperatures.
Portal
